Related Experiment Video

Updated: Jun 14, 2025

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma

Ricardo D Parrondo¹, Betsy R LaPlant², Jamie Elliott¹

¹Department of Hematology-Oncology, Mayo Clinic Cancer Center, Jacksonville, FL, USA.

Blood Cancer Journal

|September 5, 2024

Abstract

No abstract available in PubMed .

More Related Videos

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Music Therapy for Reduction of Anhedonia: Protocol for a Sequential Mixed Methods Pre-Post Pilot Study.

JMIR research protocols·2026

Prophylactic dexamethasone at the time of absolute lymphocyte expansion does not mitigate risk or event-free survival for immune effector cell associated delayed neurotoxicity.

Blood cancer journal·2026

Safety and Management of Targeted Therapies for Relapsed/Refractory Chronic Lymphocytic Leukemia.

Drug safety·2026

Multicentre real-world evaluation of the Haematuria Cancer Risk Score to risk-stratify the detection of bladder cancer in patients referred from primary care.

BJUI compass·2026

Wandering Lymphoma: A Case of Wandering Spleen Secondary to Splenic Marginal Zone Lymphoma.

Case reports in hematology·2026

A multicenter study of progression risk and outcomes in solitary bone plasmacytoma with and without marrow involvement.

Blood advances·2026

See all related articles